Literature DB >> 9196096

Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis.

J R Curtis1, W Burke, A W Kassner, M L Aitken.   

Abstract

Life expectancy for individuals with cystic fibrosis (CF) has increased dramatically in the last 30 yr, but it is unclear whether the improved survival has applied equally to individuals with different health insurance status. We developed a retrospective inception cohort of all 189 patients with CF born 1/1/55 to 12/31/70 who had at least one hospitalization at a university referral center. The median survival for patients with CF who were without health insurance was 6.1 yr compared with 20.5 yr for those with Medicaid and 20.5 yr for those with private insurance. Using multivariate Cox regression, health insurance and increased socioeconomic status were independently associated with longer survival. The adjusted relative risk of death was greater for the absence of health insurance than for factors previously shown to predict mortality in individuals with CF (female sex and presentation with meconium ileus). In summary, the absence of health insurance was associated with increased mortality rate in children with CF and was a stronger predictor of mortality than variables previously shown to be associated with mortality for CF. If increasing numbers of children with CF lose health insurance coverage, our results suggest that their life expectancy will decrease dramatically.

Entities:  

Mesh:

Year:  1997        PMID: 9196096     DOI: 10.1164/ajrccm.155.6.9196096

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

1.  Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function.

Authors:  J Michael Collaco; Scott M Blackman; John McGready; Kathleen M Naughton; Garry R Cutting
Journal:  J Pediatr       Date:  2010-06-30       Impact factor: 4.406

2.  Marked improvement in cystic fibrosis lung disease and nutrition following change in home environment.

Authors:  Atul Gupta; Donald Urquhart; Mark Rosenthal
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

3.  Cat and dog exposure and respiratory morbidities in cystic fibrosis.

Authors:  Christopher B Morrow; Karen S Raraigh; Deanna M Green; Scott M Blackman; Garry R Cutting; Joseph M Collaco
Journal:  J Pediatr       Date:  2014-07-12       Impact factor: 4.406

4.  Impact of Socioeconomic Position on Access to the U.S. Lung Transplant Waiting List in a Matched Cystic Fibrosis Cohort.

Authors:  Carli J Lehr; Aliza K Fink; Melissa Skeans; Albert Faro; Gabriela Fernandez; Elliott Dasenbrook; Maryam Valapour
Journal:  Ann Am Thorac Soc       Date:  2020-11

5.  Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013.

Authors:  Abhinav Agrawal; Abhishek Agarwal; Dhruv Mehta; Rutuja R Sikachi; Doantrang Du; Janice Wang
Journal:  Intractable Rare Dis Res       Date:  2017-08

6.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

7.  Inpatient healthcare trends among adult cystic fibrosis patients in the U.S.

Authors:  Benjamin T Kopp; Wei Wang; Deena J Chisolm; Kelly J Kelleher; Karen S McCoy
Journal:  Pediatr Pulmonol       Date:  2011-09-07

8.  Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status.

Authors:  Bradley S Quon; Kevin Psoter; Nicole Mayer-Hamblett; Moira L Aitken; Christopher I Li; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2012-09-13       Impact factor: 21.405

9.  Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis.

Authors:  Joseph M Collaco; Karen S Raraigh; Lawrence J Appel; Garry R Cutting
Journal:  J Cyst Fibros       Date:  2016-06-11       Impact factor: 5.482

Review 10.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.